D. Porter

Oncology · New England Journal of Medicine · 2011–2022

A researcher in the Science corpus: 14 papers; trusts 2 researchers and is trusted by 9 researchers here, as inferred from the citation graph.

Subfields

Whom D. Porter trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Milone
  2. B. Levine

Who trusts D. Porter overall

  1. Jennifer N. Brudno
  2. J. Kochenderfer
  3. S. Maude
  4. D. Teachey
  5. C. June
  6. N. Restifo
  7. Kole T. Roybal
  8. Wendell A. Lim
  9. C. Dunbar
  10. Kathryn M. Cappell

Papers from D. Porter's perspective

Ordered by how strongly the researchers D. Porter trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (New England Journal of Medicine)
  2. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia (Science Translational Medicine)
  3. A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer (Clinical Cancer Research)
  4. Immunological aspects of cancer chemotherapy (Nature reviews. Immunology)
  5. HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma (JAMA Oncology)
  6. Familial and acquired hemophagocytic lymphohistiocytosis (European Journal of Pediatrics)
  7. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia (Science Translational Medicine)
  8. IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6 (International Journal on Biological Sciences)
  9. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis (Pediatric Blood & Cancer)
  10. A Simple Sequentially Rejective Multiple Test Procedure

Their papers